KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Alnylam Pharmaceuticals (ALNY) Change in Inventory: 2018-2024

Historic Change in Inventory for Alnylam Pharmaceuticals (ALNY) over the last 7 years, with Dec 2024 value amounting to -$13.6 million.

  • Alnylam Pharmaceuticals' Change in Inventory rose 16.02% to -$5.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$23.2 million, marking a year-over-year increase of 6.26%. This contributed to the annual value of -$13.6 million for FY2024, which is 26.01% up from last year.
  • Alnylam Pharmaceuticals' Change in Inventory amounted to -$13.6 million in FY2024, which was up 26.01% from -$18.4 million recorded in FY2023.
  • Alnylam Pharmaceuticals' 5-year Change in Inventory high stood at $35.4 million for FY2020, and its period low was -$18.4 million during FY2023.
  • Moreover, its 3-year median value for Change in Inventory was -$13.6 million (2024), whereas its average is $726,333.
  • Its Change in Inventory has fluctuated over the past 5 years, first grew by 29.23% in 2022, then tumbled by 153.81% in 2023.
  • Alnylam Pharmaceuticals' Change in Inventory (Yearly) stood at $35.4 million in 2020, then fell by 25.44% to $26.4 million in 2021, then climbed by 29.23% to $34.1 million in 2022, then crashed by 153.81% to -$18.4 million in 2023, then rose by 26.01% to -$13.6 million in 2024.